Chang Yu Pan

Summary

Country: China

Publications

  1. ncbi Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective
    C Y Pan
    Chinese PLA General Hospital, Beijing, People s Republic of China
    Diabetes Technol Ther 10:397-403. 2008
  2. ncbi The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
    Da yi Hu
    Centre for Cardiovascular and Pulmonary Blood Vessels, Tongji University, Shanghai, China
    Eur Heart J 27:2573-9. 2006
  3. ncbi Reducing the risk of type 2 diabetes: early identification of high-risk individuals and treatment with acarbose
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
    Curr Diabetes Rev 3:141-8. 2007
  4. ncbi Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studies
    C Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
    Diabet Med 29:515-21. 2012
  5. ncbi Efficacy and safety of saxagliptin in drug-naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial
    Chang Yu Pan
    Department of Endocrinology, General Hospital of Chinese People s Liberation Army, Beijing, China
    Diabetes Metab Res Rev 28:268-75. 2012
  6. ncbi Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA Hospital, 28 Fuxing Road, Beijing 100853, China
    Diabetes Res Clin Pract 76:111-8. 2007
  7. ncbi Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China
    Chang Yu Pan
    Department of Endocrinology, 301 Hospital, Beijing, China
    Clin Drug Investig 27:397-405. 2007
  8. ncbi [A comparison of efficacy and tolerance of nateglinide and acarbose monotherapy in type 2 diabetes mellitus]
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 48:304-7. 2009
  9. ncbi Efficacy of acarbose in Chinese subjects with impaired glucose tolerance
    Chang Yu Pan
    Beijing 301 Hospital, Beijing, China
    Diabetes Res Clin Pract 61:183-90. 2003
  10. ncbi [Effects of candesartan on expressions of JAK2 and PTP-1B in adipose tissue of high-fat diet-fed rats]
    Wen hua Yan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 90:1836-40. 2010

Collaborators

Detail Information

Publications44

  1. ncbi Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective
    C Y Pan
    Chinese PLA General Hospital, Beijing, People s Republic of China
    Diabetes Technol Ther 10:397-403. 2008
    ..This study aimed to describe the prevalence of albuminuria, CV risk factors, and treatments for renal and CV protection in an Asian population with type 2 diabetes...
  2. ncbi The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
    Da yi Hu
    Centre for Cardiovascular and Pulmonary Blood Vessels, Tongji University, Shanghai, China
    Eur Heart J 27:2573-9. 2006
    ..The aim of this article is to characterize the glucometabolic state of patients with coronary artery disease (CAD) in China...
  3. ncbi Reducing the risk of type 2 diabetes: early identification of high-risk individuals and treatment with acarbose
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
    Curr Diabetes Rev 3:141-8. 2007
    ..Identification of high-risk individuals should therefore be standard in general practice and, if IGT is diagnosed, therapeutic intervention should be initiated promptly...
  4. ncbi Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studies
    C Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
    Diabet Med 29:515-21. 2012
    ..To describe the status of glycaemic control, self-reported adherence to treatments, psychological well-being and quality of life in Chinese patients with Type 2 diabetes in 2006...
  5. ncbi Efficacy and safety of saxagliptin in drug-naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial
    Chang Yu Pan
    Department of Endocrinology, General Hospital of Chinese People s Liberation Army, Beijing, China
    Diabetes Metab Res Rev 28:268-75. 2012
    ..Few studies have assessed the use of new oral anti-diabetic agents in Asian populations. This study assesses the efficacy and safety of saxagliptin versus placebo in Asian patients with type 2 diabetes mellitus (T2DM)...
  6. ncbi Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA Hospital, 28 Fuxing Road, Beijing 100853, China
    Diabetes Res Clin Pract 76:111-8. 2007
    ..This study investigated the effect of insulin glargine (LANTUS) versus NPH insulin on metabolic control and safety in Asian patients with Type 2 diabetes, inadequately controlled on oral hypoglycemic agents (OHAs)...
  7. ncbi Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China
    Chang Yu Pan
    Department of Endocrinology, 301 Hospital, Beijing, China
    Clin Drug Investig 27:397-405. 2007
    ..Subjects with IGT were included in analyses because acarbose has been approved for treatment of this condition since 2002...
  8. ncbi [A comparison of efficacy and tolerance of nateglinide and acarbose monotherapy in type 2 diabetes mellitus]
    Chang Yu Pan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 48:304-7. 2009
    ..To compare the efficacy and tolerability of nateglinide with those of acarbose in Chinese type 2 diabetes mellitus (T2DM) patients...
  9. ncbi Efficacy of acarbose in Chinese subjects with impaired glucose tolerance
    Chang Yu Pan
    Beijing 301 Hospital, Beijing, China
    Diabetes Res Clin Pract 61:183-90. 2003
    ..Acarbose is efficacious in improving the metabolic state of individuals with impaired glucose tolerance indicating a potential benefit for the delay or prevention of onset of Type 2 diabetes in Chinese subjects...
  10. ncbi [Effects of candesartan on expressions of JAK2 and PTP-1B in adipose tissue of high-fat diet-fed rats]
    Wen hua Yan
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 90:1836-40. 2010
    ..To observe the effects of candesartan on the expressions of JAK2 and protein tyrosine phosphatase-1B (PTP-1B) in adipose tissue of obese rats induced by high-fat diet...
  11. ncbi [The reproducibility and clinical significance of oral glucose tolerance test for abnormal glucose metabolism]
    Min Liu
    Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
    Zhonghua Nei Ke Za Zhi 46:1007-10. 2007
    ..To examine the reproducibility of oral glucose tolerance test (OGTT) in screening abnormal glucose metabolism in Chinese population...
  12. ncbi [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics]
    Yan Gao
    Department of Endocrinology, Peking University First Hospital, Beijing 100034, China
    Zhonghua Yi Xue Za Zhi 89:1960-3. 2009
    ..To compare the efficacy and safety of insulin aspart (IAsp) and human insulin (HI) when applied as meal-time insulin with neutral protamine Hagedorn insulin (NPH) at bedtime in diabetics...
  13. ncbi [The mechanism of homocysteine in Kkay mice diabetic nephropathy model]
    Ju Ming Lu
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 43:604-7. 2004
    ..To study the expression of matrix metalloproteinase-9 (MMP-9) in diabetic nephropathy of Kkay mice with hyperhomocysteinemia...
  14. ncbi Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: a randomized controlled trial
    Wenying Yang
    Department of Endocrinology, China Japan Friendship Hospital, Yinhua No 2 East Road, Hepingli, Chao Yang District, Beijing 100029, China
    Diabetes Res Clin Pract 94:217-24. 2011
    ..To assess efficacy and safety of saxagliptin added to metformin versus placebo plus metformin in Asian patients with type 2 diabetes mellitus (T2DM) and inadequate glycemic control on metformin alone...
  15. ncbi Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma
    Xian Ling Wang
    Department of Endocrinology, Chinese People s Liberation Army General Hospital, Beijing 100853, China
    Chin Med J (Engl) 124:3820-3. 2011
    ..We investigated the clinical characteristics of patients with spontaneous partial remission of acromegaly or gigantism due to subclinical apoplexy of GH adenoma...
  16. ncbi [A survey of microalbuminuria prevalence in hypertensive type 2 diabetic patients in mainland China]
    Jin Du
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 46:184-8. 2007
    ..To determine the prevalence and risk factors of microalbuminuria (MA) in diabetic patients with hypertension in mainland China...
  17. ncbi [Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonases/paraoxonase activity in patients with type 2 diabetes mellitus]
    Wei Jun Gu
    Department of Endocrinology, General Hospital of Chinese People s Liberation Army, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 87:256-8. 2007
    ..To study the effects of methylcobalamin and folic acid treatment on plasma homocysteine (Hcy) level and homocysteine thiolactonase/paraoxonase (HTase/PON) activity in patients with type 2 diabetes mellitus...
  18. ncbi [Two-year follow-up for patients with pre-diabetes that reverted to normal glucose in the first year]
    Yan hui Lu
    Department of Geriatric Endocrinology, General Hospital of People s Liberation Army, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 88:1394-7. 2008
    ..To investigate the natural outcome in the second year of the patients with impaired glucose regulation (IGR) that reverted to normal glucose tolerance (NGT)...
  19. ncbi Evaluation of the superiority of insulin glargine as basal insulin replacement by continuous glucose monitoring system
    Xian Ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, Fu Xing Road 28, Beijing 100853, China
    Diabetes Res Clin Pract 76:30-6. 2007
    ..So glargine may be a more ideal basal insulin replacement than NPH...
  20. ncbi [Multiple endocrine neoplasia type 1 presenting as hypoglycemic coma: a report of four cases and review of literatures]
    Xian Ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 48:13-6. 2009
    ..To investigate the clinical characteristics of multiple endocrine neoplasia type 1 (MEN1) patients presenting with hypoglycemic coma as chief manifestation and the related clinical experience in diagnosis and therapy...
  21. ncbi A case of relapsed autoimmune hypothalamitis successfully treated with methylprednisolone and azathioprine
    Xian Ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, Fuxing Road 28, Beijing, China
    Neuro Endocrinol Lett 29:874-6. 2008
    ..This case report suggested that HDMPT in combination with azathioprine therapy might be an effective trial for autoimmune hypothalamitis treatment...
  22. ncbi A young boy with diffuse hyperpigmentation and delayed puberty
    Xian Ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, 28 Fu Xing Road, Beijing, China 100853
    Eur J Pediatr 170:671-3. 2011
    ..14 mmol/L) and plasma adrenocorticotropic hormone (>275 pmol/L), however, a low concentration of plasma free cortisone (<25.1-67.6 nmol/L). Abdomen computed tomography detected atrophy of both adrenals glands...
  23. ncbi Medullar thyroid carcinoma in mediastinum initially presenting as Ectopic ACTH syndrome. A case report
    Xian Ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Neuro Endocrinol Lett 32:421-4. 2011
    ..After surgery, serum levels of kalium, as well as cortisol and ACTH returned to normal range. During follow-up, the patient's clinical manifestation of Cushing syndrome relieved...
  24. ncbi [Candesartan improves insulin resistance induced by high-fat diet in rats]
    Wen hua Yan
    Department of Endocrinology, Chinese People s Liberation Army General Hospital, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 88:2695-9. 2008
    ..To investigate the effects of candesartan, an angiotension II type I receptor antagonist, in improvement of insulin resistance (IR) induced by high-fat diet and the possible mechanism thereof...
  25. ncbi [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus]
    Guang Wei Li
    Department of Endocrinology, China Japan Friendship Hospital, Beijing 100029, China
    Zhonghua Nei Ke Za Zhi 43:510-4. 2004
    ..To evaluate the efficacy and safety profile of a slow-released-gliclazide (Diamicron MR) in type 2 diabetes patients...
  26. ncbi Chronic inflammatory demyelinating polyneuropathy mimicking diabetic neuropathy in a young female with type 2 diabetes mellitus
    Xian Ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
    Diabetes Res Clin Pract 96:e15-7. 2012
    ..We described a young girl with CIDP underlying type 2 diabetes mellitus, presenting with progressive numbness and limb weakness, who was initially misdiagnosed to have DPN. Finally immunosuppressive therapy got good response...
  27. ncbi [Detrimental effects of homocysteine on insulin release and apoptosis of pancreatic beta cells]
    Yao Zhang
    Department of Endocrinology, General Hospital of Chinese People s Liberation Army, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 88:990-3. 2008
    ..To study the effects of homocysteine (Hcy) on the insulin secretion and apoptosis of pancreatic beta cells...
  28. ncbi [The expression of G proteins alpha-subunit mRNA in different thyroid diseases]
    Zhao Hui Lu
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 42:103-5. 2003
    ..To investigate the expression of G proteins alpha subunit mRNA in different thyroid diseases...
  29. ncbi [The clinical features of ectopic ACTH syndrome: a report of 16 cases]
    Yan Yang
    Department of Geriatric Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 49:606-9. 2010
    ..To improve the diagnostic and therapeutic ability of ectopic ACTH syndrome by analysing its clinical features...
  30. ncbi [Association between fasting plasma glucose and the 5 years outcome post PCI in aged patients with coronary artery disease]
    Hai yan Su
    Department of Endocrinology, Chinese People s Liberation Army General Hospital, Beijing 100853, China
    Zhonghua Xin Xue Guan Bing Za Zhi 36:710-3. 2008
    ..To observe the association between fasting plasma glucose (FPG) and 5 years outcome post PCI in aged patients with coronary artery disease (CAD)...
  31. ncbi [A survey of factors influencing prognosis and control rate for patients with hypertension in mainland China]
    Wen Hang Qi
    Shanghai Rui Jin Hospital, Jiao Tong University, Shanghai, China
    Zhonghua Xin Xue Guan Bing Za Zhi 35:457-60. 2007
    ..To observe the risk factor stratification and prevalence of target organ damage in hypertensive patients before therapy and blood pressure control rate after 4 or 12 weeks antihypertensive drug therapy...
  32. ncbi [A randomized, double blind, placebo-controlled, parallel and multicenter study to evaluate the safety and efficacy of pioglitazone with sulphonyurea in type 2 diabetic patients]
    Zhao Hui Lu
    Department of Endocrinology, PLA General Hospital, Beijing, China
    Zhonghua Nei Ke Za Zhi 50:826-30. 2011
    ..To evaluate the safety and efficacy of 30 mg pioglitazone hydrochloride combined with sulphonyurea in the treatment of type 2 diabetic patients...
  33. ncbi [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China]
    Qing hua Guo
    Department of Endocrinology, General Hospital of Chinese People s Liberation Army, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 88:240-4. 2008
    ..To prospectively evaluate the current situation of blood pressure control in the type 2 diabetics in some regions of China...
  34. ncbi [Association between metabolic syndrome and the 10 years mortality of cerebro-cardiovascular diseases in the senile population]
    Meng meng Jin
    Department of Endocrinology, People s Liberation Army Hospital, Beijing 100853, China
    Zhonghua Xin Xue Guan Bing Za Zhi 36:118-22. 2008
    ..To assess the prevalence of metabolic syndrome (MS) and its association with mortality of cerebro-cardiovascular diseases in senile population...
  35. ncbi [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system]
    Xian-ling Wang
    Department of Endocrinology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 86:674-7. 2006
    ..3) With the deterioration of glucose tolerance, the postprandial glucose peak is elevated higher and more rapidly, and the daily blood glucose profile excursion becomes more and more fluctuant...
  36. ncbi [Cross-sectional study on the prevalence of metabolic syndrome in patients with coronary heart disease in China]
    Hao Liu
    Center for Cardiovascular and Pulmonary Blood Vessel, Tongji University, Shanghai 200092, China
    Zhonghua Yi Xue Za Zhi 86:2095-8. 2006
    ..CONCLUSION: The prevalence of MS in CHD patients is rather high in China. It is important to screen for MS in patients with high risk for new vascular incidents...
  37. ncbi [A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects]
    Xian-ling Wang
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 43:170-3. 2004
    ..It is suggested that in early stage of abnormal glucose tolerance, postprandial hyperglycemia might be a more important risk factor for UAE and prevalence of MAU than isolated fasting hyperglycemia...
  38. ncbi [A pilot evaluation of the diagnostic value of body mass index in elderly men with metabolic syndrome]
    Ying Cheng
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 45:100-3. 2006
    ..In the population with the above mentioned diseases, the prevalence of metabolic syndrome is high and the BMI of these patients is significantly increased...
  39. ncbi [The relationship between metabolic control and the plasma total homocysteine in type 2 diabetes treated with insulin]
    Guo-Qing Yang
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 45:34-7. 2006
    ..The plasma tHcy decreased significantly as well. CONCLUSIONS: After insulin treatment, the plasma tHcy decreases when the metabolic control is improved significantly...
  40. ncbi [Metabolic syndrome: a high-cardiovascular risk]
    Chang-yu Pan
    Zhonghua Nei Ke Za Zhi 43:801-2. 2004
  41. ncbi [The impact of pioglitazone on plasma homocysteine high-fat diet-induced insulin resistance in rats]
    Guo-Qing Yang
    Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
    Zhonghua Nei Ke Za Zhi 44:38-41. 2005
    ..031) and HOMA IR (r = 0.302, P = 0.046) independently affected the level of plasma homocysteine. CONCLUSION: It is concluded that pioglitazone can lower plasma homocysteine in insulin resistant Wistar rats induced by high-fat diet...
  42. ncbi [Monitoring microalbuminuria and prevention of diabetic nephropathy]
    Chang-yu Pan
    Zhonghua Nei Ke Za Zhi 43:161-2. 2004
  43. ncbi [Study of the gene expression pattern in the Kkay mouse with type 2 diabetes by genomic-scale gene expression analysis]
    Qing-hua Guo
    Endocrinology Department, General Hospital of PLA, Beijing 100853, China
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24:462-5. 2002
    ....
  44. ncbi [Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch]
    Yan-hui Lu
    Department of Endocrinology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China
    Zhonghua Yi Xue Za Zhi 86:386-9. 2006
    ..77). CONCLUSION: The MS diagnostic criteria of IDF and that of CMA Diabetes Branch are in good accordance...